Concord Medical Services Holdings Ltd (CCM) Stock Analysis

AI analysis of Concord Medical Services Holdings Ltd (CCM)

Buy

Concord Medical Services Holdings Ltd is a good buy right now due to its recent positive price momentum and improving financial metrics. The stock has increased by 3.92% over the last five days and has a forward P/E of 11.30, suggesting it may be undervalued compared to its earnings potential. Additionally, the gross margin has improved to 11.58%, indicating better operational efficiency. However, the main risk is the significant net loss of 32.8 million CNY in Q3 2025, which could impact future performance.

Analyst Ratings (1)

Sell

0 Buy

0 Hold

1 Sell

Current: 3.71

Low

—

Average

—

High

—

See All Ratings

Valuation Metrics

The current forward P/E ratio for Concord Medical Services Holdings Ltd (CCM) is 11.30, compared to its 5-year average forward P/E of -31.33.

Forward P/E

Overvalued

5Y Average P/E

-31.33

Current P/E

11.30

Overvalued

-7.56

Undervalued

-55.11

Forward EV/EBITDA

Undervalued

5Y Average EV/EBITDA

58.46

Current EV/EBITDA

0.00

Overvalued

98.90

Undervalued

18.03

Forward P/S

Undervalued

5Y Average P/S

1.04

Current P/S

0.00

Overvalued

1.59

Undervalued

0.48

Alphio AI Price Scenarios for CCM

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%CCM

$5.00

Scenario price

B

Base

Base · 50%CCM

$4.82

Scenario price

B

Bear

Bear · 25%CCM

$4.59

Scenario price

CCM FAQ — answered by Alphio AI

Concord Medical Services Holdings Ltd is an investment holding company primarily engaged in the provision of comprehensive solutions for cancer medical treatment. The Company operates its business through two segments. The Network segment is engaged in providing enterprise customers with integrated oncology-related solutions, including primarily the supply, management and technical support for medical equipment and software solutions, and providing equipment leasing and comprehensive support services. The Hospital segment is engaged in providing a full spectrum of oncology healthcare services to cancer patients across the entire care continuum through its self-owned cancer hospitals and clinics. The Company mainly conducts its business in the domestic market. It operates in the Healthcare sector (OFFICES AND CLINICS OF DOCTORS OF MEDICINE industry).

Concord Medical Services Holdings Ltd is a good buy right now due to its recent positive price momentum and improving financial metrics. The stock has increased by 3.92% over the last five days and has a forward P/E of 11.30, suggesting it may be undervalued compared to its earnings potential. Additionally, the gross margin has improved to 11.58%, indicating better operational efficiency. However, the main risk is the significant net loss of 32.8 million CNY in Q3 2025, which could impact future performance.

1 analysts cover CCM: 0 rate it Buy, 0 Hold and 1 Sell.